ASPIRE-AF - Research Studies - PHRI - Population Health Research Institute of Canada
The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis
ASPIRE Stroke TRIAL
Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE)
PPT - Aspirin for the prevention of recurrent venous thromboembolism (VTE) after a first PowerPoint Presentation - ID:6798704
CANaspire Trial - A Clinical Trial for Canavan Disease
Timeline of the ASPIRE trial and COVID-19 pandemic in South Africa | Download Scientific Diagram